moclobemide has been researched along with Acute Brain Injuries in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newburn, G | 1 |
| Edwards, R | 1 |
| Thomas, H | 1 |
| Collier, J | 1 |
| Fox, K | 1 |
| Collins, C | 1 |
1 trial available for moclobemide and Acute Brain Injuries
| Article | Year |
|---|---|
Moclobemide in the treatment of major depressive disorder (DSM-3) following traumatic brain injury.
Topics: Adolescent; Adult; Brain Injuries; Child; Depressive Disorder; Female; Humans; Male; Middle Aged; Mo | 1999 |